Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on January 22nd, 2025 | 07:00 CET
Evotec, Vidac Pharma, BioNTech – Profiting from the fight against cancer
It has been clear for some time that cancer can affect anyone, and not just since King Charles and Princess Kate made their battles with cancer public. The market is growing, and today, revenues in this area are already in the billions. This is driven by an aging population and increasingly unhealthy lifestyles. The margins for manufacturers of cancer drugs are often in the high double-digit percentage range. It is no wonder that companies are focusing on the fight against cancer. Developing a medication that reliably defeats the disease could result in a genuine blockbuster. In 2023, around USD 223 billion was spent on cancer drugs worldwide. We are looking at three companies striving to cure cancer and claim their share of this lucrative market.
Read
Commented by Armin Schulz on January 21st, 2025 | 07:30 CET
Bayer awakened! BioNxt Solutions, Novo Nordisk – Invest in tomorrow's winners today
The economy is at a turning point, as the rapid advancements in artificial intelligence are enabling technological innovations that set new benchmarks. Revolutionary developments are emerging, particularly in the pharmaceutical industry, medical technology, and biotechnology. These sectors not only unlock groundbreaking medical possibilities but also offer significant economic growth potential. Investors who move in early to disruptive technologies or dynamic growth industries can count on attractive returns. But which players are dominating this wave of innovation? And how can you, as an investor, benefit strategically? A closer look is worthwhile.
Read
Commented by Armin Schulz on January 15th, 2025 | 07:10 CET
Rheinmetall, Power Nickel, and BYD in focus – The winners of the next decade
The stock markets are currently rewarding companies that are focusing on future markets – a trend from which Rheinmetall, BYD, and Power Nickel are benefiting. Rheinmetall is securing lucrative major orders in the defense sector and is thus taking advantage of government investments. BYD is driving forward its leading position in the field of e-mobility with determined expansion, thereby responding to the global shift towards sustainable mobility. Power Nickel is developing essential raw material bases to drive the energy transition forward – a key to decarbonization. For investors, these companies represent not just visions but real opportunities for sustainable and attractive returns.
Read
Commented by Armin Schulz on January 14th, 2025 | 08:05 CET
Plug Power, F3 Uranium, Super Micro Computer – The energy crisis intensifies
In Germany, the energy crisis is coming to a head. Due to the "dark doldrums" that occur more frequently during the winter months, electricity costs have exploded during these periods. Germany's European neighbours are already complaining because their electricity prices are also rising due to the high German electricity imports. Without gas imports from Russia, Germany previously had a base load power capacity supported by its remaining nuclear power plants. However, this is now only achievable through fossil fuels, resulting in a poor environmental record. While other countries are expanding nuclear power and fighting over uranium to satisfy their hunger for energy, Germany is going it alone. Perhaps the turning point will come with the next federal election in February.
Read
Commented by Armin Schulz on January 8th, 2025 | 07:30 CET
Bayer, First Hydrogen, Volkswagen – Turnaround Candidates for 2025 Under Review
After the year-end portfolio window-dressing in December, the new year starts with the hunt for the right stocks for 2025. Special attention should be given to turnaround candidates, meaning stocks that underperformed last year. These companies have faced challenging times and have often already begun addressing their issues through strategic realignment. Sometimes, market conditions for a sector can improve significantly from one year to the next, and then the stocks of these companies often rise disproportionately. Identifying the right stocks requires thorough research. We look at three potential turnaround candidates.
Read
Commented by Armin Schulz on January 6th, 2025 | 07:15 CET
Volkswagen undervalued! What about European Lithium and BYD?
Looking at the market for electric vehicles in Germany, the outlook seems bleak. However, taking a broader view, the global picture tells a different story. Battery production is also steadily rising, driving a growing demand for lithium. Currently, the lithium supply is still sufficient, but experts predict that by 2030 demand will exceed supply. The reason for this is not only the automotive industry but also the demand for energy storage for renewable energies. We take a look at three companies and their current situation.
Read
Commented by Armin Schulz on January 3rd, 2025 | 07:00 CET
D-Wave Quantum, ARI Motors, Bayer – Which stocks should be in the portfolio for 2025?
After Google presented its quantum processor, Willow, D-Wave Quantum's shares skyrocketed. The question is how sustainable this increase is and whether quantum computing will be the next big hype after artificial intelligence. For the automotive industry, 2024 was a year to forget. Many automakers are currently struggling with problems. ARI Motors, an electric vehicle manufacturer that has secured a niche for itself, is faring better. Will the entire automotive industry manage a turnaround in the coming year? Bayer's shareholders are also hoping for a turnaround. The share price took a significant hit last year. 2025 is expected to be much better. We take a closer look at the individual stocks.
Read
Commented by Armin Schulz on January 2nd, 2025 | 07:10 CET
Palantir – Data as gold, or should one add Desert Gold and MicroStrategy to the portfolio for 2025?
In today's world, digital technologies are integral to our lives, and as we navigate the internet, we disclose data that is now considered the gold of the 21st century. Tech giants leverage this data for personalised offerings, thereby securing competitive advantages. Palantir has made a name for itself as a big data analyst and has grown considerably as a result. The other option is to invest in gold or crypto companies. The price of gold and Bitcoin has risen significantly in the past year. We look at a company from each sector and see which stock deserves a place in your portfolio.
Read
Commented by Armin Schulz on December 30th, 2024 | 07:10 CET
Myriad Uranium - Uranium prices are exploding! What is the outlook for Nel ASA and RWE?
Uranium is increasingly coming into focus. Recently, the largest uranium producers, Kazatomprom and Cameco, revised their production forecasts downward, and this at a time when the world needs more energy. Data centres for quantum computing, crypto mining, artificial intelligence, and electromobility are driving the world's hunger for electricity. At the same time, some large tech companies are researching modular nuclear reactors, which could further boost the demand for uranium. While the uranium sector is performing well, 2024 has been a tough year for hydrogen and renewable energies. We look at one company from each sector and examine the prospects for 2025.
Read
Commented by Armin Schulz on December 27th, 2024 | 07:10 CET
Volkswagen, Globex Mining, Novo Nordisk – Here are the opportunities for the coming year
The vbw commodity price index recorded a remarkable increase of 4.4% in October 2024 compared to the previous month – an increase of 18.4% year-on-year. On the one hand, this is surprising, as the economy has reportedly noticeably slowed down. On the other hand, geopolitical tensions seem to be causing overcompensation. Raw materials are the engine of the economy, and it is not for nothing that the price of copper is considered a leading indicator of economic activity. In times of export restrictions, it is clear how dependent the world is on China and Russia. Without the crucial raw materials, production comes to a halt. We take a look at three companies and assess whether they are well-positioned in the raw materials sector for the upcoming year.
Read